Stem cell transplantation after alemtuzumab in T‐cell prolymphocytic leukaemia results in longer survival than after alemtuzumab alone: a multicentre retrospective study
- 20 May 2010
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 149 (6), 907-910
- https://doi.org/10.1111/j.1365-2141.2010.08134.x
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Prolymphocytic leukaemia of B‐ and T‐cell subtype: a state‐of‐the‐art paperEuropean Journal of Haematology, 2008
- Campath-1H Treatment of T-Cell Prolymphocytic Leukemia in Patients for Whom at Least One Prior Chemotherapy Regimen Has FailedJournal of Clinical Oncology, 2002
- High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1HBlood, 2001
- The role of pentostatin in the treatment of T-cell malignancies: analysis of response rate in 145 patients according to disease subtype.Journal of Clinical Oncology, 1994
- Clinical and laboratory features of 78 cases of T-prolymphocytic leukemiaBlood, 1991